G. Antonelli

发表

Consolidation of molecular testing in clinical virology

C. Scagnolari, O. Turriziani, K. Monteleone, 2017, Expert review of anti-infective therapy.

Virological and clinical characterization of respiratory infections in children attending an emergency department during the first autumn–winter circulation of pandemic A (H1N1) 2009 influenza virus

C. Scagnolari, K. Monteleone, A. Pierangeli, 2011, Clinical Microbiology and Infection.

Interferon lambda 1–3 expression in infants hospitalized for RSV or HRV associated bronchiolitis

C. Scagnolari, A. Pierangeli, G. Antonelli, 2014, Journal of Infection.

Novel Insights and Features of the NDM-5-Producing Escherichia coli Sequence Type 167 High-Risk Clone

G. Antonelli, A. Carattoli, L. Villa, 2020, mSphere.

Novel Insights and Features of the NDM-5-Producing Escherichia coli Sequence Type 167 High-Risk Clone

G. Antonelli, L. Villa, M. Venditti, 2020 .

HCV derived from sera of HCV-infected patients induces pro-fibrotic effects in human primary fibroblasts by activating GLI2

G. Antonelli, M. Cirone, M. Torrisi, 2016, Scientific Reports.

Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy

A. Lazzarin, O. Turriziani, G. Antonelli, 2008, Journal of medical virology.

Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group.

A. d’Arminio Monforte, F. Baldanti, F. Ceccherini‐Silberstein, 2012, The new microbiologica.

Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group.

F. Baldanti, F. Ceccherini‐Silberstein, R. Maserati, 2010, The new microbiologica.

Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV‐1‐infected male patients

C. Scagnolari, G. Antonelli, E. N. Cavallari, 2021, Journal of medical virology.

Mechanisms of Action of Antiviral Agents

O. Turriziani, G. Antonelli, 2015, Practical Handbook of Microbiology.

Drug Combination of AZT and ddl: Synergism of Action and Prevention of Appearance of AZT-Resistance

O. Turriziani, G. Antonelli, F. Dianzani, 1994 .

In vitro selection of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine.

O. Turriziani, G. Antonelli, M. Capobianchi, 1992, Antiviral research.

Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors.

O. Turriziani, G. Antonelli, G. Palù, 2017, Journal of global antimicrobial resistance.

Immunogenicity comparison of interferon beta-1a preparations using the BALB/c mouse model: assessment of a new formulation for use in multiple sclerosis.

G. Antonelli, C. Dianzani, G. Palmieri, 2007, The new microbiologica.

Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: Prevalence, etiology, and management

G. Mancia, G. Antonelli, D. Ravizza, 1995, Hepatology.

Interferon antibodies in patients with infectious diseases

G. Antonelli, F. Dianzani, M. Pistello, 1997, Biotherapy.

Interferon antibodies in patients with infectious diseases. Anti-interferon antibodies.

G. Antonelli, F. Dianzani, M. Pistello, 1997 .

Copy-Years Viremia and Risk of Virological Failure in Long-Term–Treated HIV Patients

O. Turriziani, G. Antonelli, G. d’Ettorre, 2019, Journal of acquired immune deficiency syndromes.

Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection.

L. Pucillo, G. Antonelli, L. Bonomo, 1997, Blood.

Cunningham virus : an overview on biology and disease of the etiological agent of the progressive multifocal leukoencephalopathy

G. Antonelli, F. Bagnato, V. Pietropaolo, 2018 .

John Cunningham virus: an overview on biology and disease of the etiological agent of the progressive multifocal leukoencephalopathy.

G. Antonelli, F. Bagnato, V. Pietropaolo, 2018, The new microbiologica.

The in vitro antiviral activity of tumor necrosis factor (TNF) in WISH cells is mediated by IFN-β induction

G. Antonelli, F. Dianzani, V. Ruggiero, 1989 .

Human Papillomaviruses and genital co-infections in gynaecological outpatients

A. Pierangeli, G. Antonelli, M. Bucci, 2009, BMC infectious diseases.

Expression of the mRNA levels for MDR1, MRP1, MRP4, and MRP5 in HIV antiretroviral naive patients: follow-up at 48 weeks after the beginning of therapy.

O. Turriziani, K. Monteleone, G. Antonelli, 2011, Journal of acquired immune deficiency syndromes.

Reverse Transcriptase Mutations in HIV-1 Infected Patients Treated with Two Nucleoside Analogues: The Smart Study

M. Moroni, A. Lazzarin, G. Antonelli, 2002, International journal of immunopathology and pharmacology.

Analysis of serum microRNAs and rs2910164 GC single-nucleotide polymorphism of miRNA-146a in COVID-19 patients

C. Scagnolari, G. Antonelli, G. d’Ettorre, 2022, Journal of immunoassay & immunochemistry.

Virological diagnosis of respiratory virus infection in patients attending an emergency department during the influenza season.

C. Scagnolari, A. Pierangeli, G. Antonelli, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Increased Sensitivity of Sars-Coronavirus to a Combination of Human Type I and Type II Interferons

C. Scagnolari, G. Antonelli, F. Dianzani, 2004, Antiviral therapy.

Early collection of saliva specimens from Bell's palsy patients: Quantitative analysis of HHV‐6, HSV‐1, and VZV

O. Turriziani, G. Antonelli, C. De Vito, 2014, Journal of medical virology.

Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study

F. Pauri, G. Antonelli, M. Altieri, 2022, Multiple sclerosis journal - experimental, translational and clinical.

Severe Acute Respiratory Syndrome Coronavirus Elicits a Weak Interferon Response Compared to Traditional Interferon-Inducing Viruses

C. Scagnolari, G. Antonelli, C. Selvaggi, 2008, Intervirology.

Respiratory syncytial virus.

C. Scagnolari, A. Pierangeli, G. Antonelli, 2018, Minerva pediatrica.

May the Drug Transporter P Glycoprotein Affect the Antiviral Activity of Human Immunodeficiency Virus Type 1 Proteinase Inhibitors?

O. Turriziani, G. Antonelli, F. Dianzani, 2000, Antimicrobial Agents and Chemotherapy.

Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab

O. Turriziani, G. Antonelli, A. Lenzi, 2020, Journal of Endocrinological Investigation.

Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease

C. Catalano, F. Fedele, F. Bilotta, 2020, Journal of Global Antimicrobial Resistance.

SARS‐CoV‐2 presence in seminal fluid: Myth or reality

O. Turriziani, G. Antonelli, A. Lenzi, 2020, Andrology.

COVID-19 in Patients with Hematologic Disorders Undergoing Therapy: Perspective of a Large Referral Hematology Center in Rome

R. Foà, O. Turriziani, G. Antonelli, 2020, Acta Haematologica.

Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox?

F. Fedele, F. Bilotta, G. Antonelli, 2021, Journal of Thrombosis and Thrombolysis.

Detection of Respiratory Viruses in the 2009 Winter Season in Rome: 2009 Influenza a (H1N1) Complications in Children and Concomitant Type 1 Diabetes Onset

C. Scagnolari, A. Pierangeli, G. Antonelli, 2011, International journal of immunopathology and pharmacology.

Proteolytic balance in patients with multiple sclerosis during interferon treatment.

C. Scagnolari, G. Antonelli, G. Giannelli, 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Frequent detection of high human papillomavirus DNA loads in oral potentially malignant disorders.

C. Scagnolari, A. Pierangeli, G. Antonelli, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

High detection rate of human papillomavirus in anal brushings from women attending a proctology clinic.

C. Scagnolari, A. Pierangeli, G. Antonelli, 2012, The Journal of infection.

Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection.

G. Antonelli, F. Dianzani, M. Milella, 2008, Liver.

Neutralising antibodies to IFN-β in patients with multiple sclerosis

G. Antonelli, M. Riva, F. Bagnato, 2006 .

Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice

D. Xing, C. Scagnolari, A. Pierangeli, 2020, Journal of Virology.

Interferon lambda4 polymorphism is not associated with human papillomavirus infection outcome

C. Scagnolari, A. Pierangeli, G. Antonelli, 2018, Virus Genes.

Interferon lambda 1 expression in cervical cells differs between low-risk and high-risk human papillomavirus-positive women

C. Scagnolari, A. Pierangeli, G. Antonelli, 2014, Medical Microbiology and Immunology.

Biological and clinical significance of neutralizing and binding antibodies to interferon‐alpha (IFN–α) during therapy for chronic hepatitis C

G. Antonelli, G. Giannelli, O. Schiraldi, 1994 .

Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients

C. Scagnolari, O. Turriziani, G. Antonelli, 2019, Medical Microbiology and Immunology.

Comparative Analysis of Real-Time Polymerase Chain Reaction Methods to Typing HLA-B*57:01 in HIV-1-Positive Patients

O. Turriziani, G. Antonelli, B. Mora, 2016, AIDS research and human retroviruses.

Identification and antimicrobial susceptibility testing of microorganisms from positive blood cultures by a combined lysis-centrifugation method with MALDI-TOF MS and VITEK2 System

G. Antonelli, M. Trancassini, V. Pietropaolo, 2017 .

Trends in drug resistance-associated mutations in a real-life cohort of Italian patients infected with HIV-1.

O. Turriziani, G. Antonelli, G. d’Ettorre, 2015, Journal of global antimicrobial resistance.

Monoclonal antibody therapy and viral infections: update and beyond.

G. Antonelli, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

A novel assay to detect low-titred antibodies to interferon beta in multiple sclerosis patients.

C. Scagnolari, G. Antonelli, P. Bramanti, 2006, The new microbiologica.

2',5'-Oligoadenylate synthetase activity as a responsive marker during interferon therapy for chronic hepatitis C.

G. Antonelli, G. Giannelli, O. Schiraldi, 1993, Journal of interferon research.

Resistance of HIV-1 to AZT might also involve the cellular expression of multidrug resistance P-glycoprotein.

A. Fattorossi, O. Turriziani, G. Antonelli, 1992, AIDS research and human retroviruses.

Emerging new technologies in clinical virology.

G. Antonelli, 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Comparative study on the antiviral activity of tumor necrosis factor (TNF)-alpha, lymphotoxin/TNF-beta, and IL-1 in WISH cells.

G. Antonelli, F. Dianzani, V. Ruggiero, 1989, Immunology letters.

Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome

C. Scagnolari, G. Antonelli, 2018, Cytokine & Growth Factor Reviews.

Physiological mechanisms of production and action of interferons in response to viral infections.

G. Antonelli, F. Dianzani, 1989, Advances in experimental medicine and biology.

HIV‐1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy

O. Turriziani, G. Antonelli, L. Calza, 2015, Journal of medical virology.

Distribution of Interferon Lambda 4 Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19

C. Scagnolari, A. Pierangeli, G. Antonelli, 2022, Microorganisms.

Neutralizing antibodies against endogenous interferon in myasthenia gravis patients.

C. Scagnolari, G. Antonelli, L. Strizzi, 2004, European cytokine network.

Interleukin-2, interleukin-2 receptor and gamma-interferon synthesis by peripheral blood mononuclear cells in chronic hepatitis delta virus infection.

G. Antonelli, C. Carini, A. Craxì, 1989, Journal of hepatology.

The biological basis for clinical use of interferon.

G. Antonelli, M. Capobianchi, F. Dianzani, 1990, Journal of hepatology.

Biological activity of gamma interferon.

G. Antonelli, M. Capobianchi, F. Dianzani, 1990, Annali dell'Istituto superiore di sanita.

Interferon lambda receptor 1 (IFNL1R) transcript is highly expressed in rhinovirus bronchiolitis and correlates with disease severity.

C. Scagnolari, A. Pierangeli, G. Antonelli, 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Recurrent wheezing 36 months after bronchiolitis is associated with rhinovirus infections and blood eosinophilia

C. Scagnolari, A. Pierangeli, G. Antonelli, 2014, Acta paediatrica.

Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients

F. Ceccherini‐Silberstein, O. Turriziani, G. Antonelli, 2022, Cells.

Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase.

P. Narciso, O. Turriziani, G. Antonelli, 1996, AIDS research and human retroviruses.

Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients

C. Scagnolari, G. Antonelli, E. Albert, 2018, Scientific Reports.

Torquetenovirus: the human virome from bench to bedside.

G. Antonelli, M. Pistello, D. Focosi, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Torquetenovirus (TTV): The Human Virome From Bench to Bedside

G. Antonelli, M. Pistello, D. Focosi, 2016 .

Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients.

C. Scagnolari, O. Turriziani, A. Pierangeli, 2019, Cytokine.

Evolutionary Trajectories toward Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Clinical Isolates

G. Antonelli, A. Carattoli, G. Raponi, 2021, Antimicrobial agents and chemotherapy.

Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy.

O. Turriziani, G. Antonelli, F. Dianzani, 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

A Multispecies Cluster of VIM-1 Carbapenemase-Producing Enterobacterales Linked by a Novel, Highly Conjugative, and Broad-Host-Range IncA Plasmid Forebodes the Reemergence of VIM-1

G. Antonelli, A. Carattoli, M. Beccaccioli, 2020, Antimicrobial Agents and Chemotherapy.

The non-functional ACE2 isoform, but not the SARS-CoV-2 receptor, is induced as an interferon-stimulated gene, in SARS-CoV-2 infected adults

C. Scagnolari, A. Pierangeli, G. Antonelli, 2022, Cytokine.

SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients

C. Scagnolari, A. Pierangeli, G. Antonelli, 2021, Microorganisms.

Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients

C. Scagnolari, O. Turriziani, A. Pierangeli, 2020, Journal of Clinical Virology.

Relationships between TT virus infection and hepatitis C virus response to interferon therapy in doubly infected patients.

G. Antonelli, M. Pistello, M. Bendinelli, 2003, Journal of biological regulators and homeostatic agents.

Rapid changes in hepatitis C virus quasispecies produced by a single dose of IFN-alpha in chronically infected patients.

G. Antonelli, M. Pistello, M. Bendinelli, 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C

C. Scagnolari, G. Antonelli, 2013, Expert opinion on biological therapy.

Antigenic characterization of recombinant, lymphoblastoid, and leukocyte IFN-alpha by monoclonal antibodies.

S. Pestka, G. Antonelli, F. Dianzani, 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Differential Toll like receptor expression in cystic fibrosis patients' airways during rhinovirus infection.

P. Palange, C. Scagnolari, A. Pierangeli, 2020, The Journal of infection.

Serological Response and Relationship with Gender-Sensitive Variables among Healthcare Workers after SARS-CoV-2 Vaccination

G. Antonelli, A. Angeloni, S. Basili, 2022, Journal of personalized medicine.

Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19)

C. Scagnolari, O. Turriziani, A. Pierangeli, 2021, Virus Research.

Expression of biomarkers of interferon type I in patients suffering from chronic diseases

C. Scagnolari, O. Turriziani, G. Antonelli, 2007, Clinical and experimental immunology.

Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω

C. Scagnolari, A. Pierangeli, G. Antonelli, 2022, Frontiers in Immunology.

Anti‐IFN‐α/‐ω neutralizing antibodies from COVID‐19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity

C. Scagnolari, A. Pierangeli, G. Antonelli, 2022, European journal of immunology.

Impaired 2',3'-dideoxy-3'-thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11.

C. Scagnolari, O. Turriziani, G. Antonelli, 2002, The Biochemical journal.

Torquetenovirus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitution.

G. Antonelli, M. Pistello, M. Bendinelli, 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN‐α2 therapy

G. Antonelli, G. Giannelli, F. Dianzani, 1996, Clinical and experimental immunology.

Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation

J. Brenchley, C. Scagnolari, G. Antonelli, 2018, Journal of immunology research.

Interplay between β herpesviruses and fungal infections in transplant patients: from the bench to the bedside

G. Antonelli, G. Gentile, 2015 .

Safety of Multiple Vaccinations and Durability of Vaccine-Induced Antibodies in an Italian Military Cohort 5 Years after Immunization

G. Antonelli, C. Castilletti, M. Capobianchi, 2021, Biomedicines.

CD 4-positive lymphoid cells rescue HIV-1 replication from abortively infected human primary endothelial cells

G. Antonelli, M. Capobianchi, F. Dianzani, 2005, Archives of Virology.

Prevalence of SARS-CoV-2 infection and associated risk factors: A testing program and nested case-control study conducted at Sapienza University of Rome between March and June 2021

O. Turriziani, G. Antonelli, V. Baccolini, 2022, Frontiers in Public Health.

Expression Levels of TLRs Involved in Viral Recognition in PBMCs from HIV-1-Infected Patients Failing Antiretroviral Therapy

C. Scagnolari, O. Turriziani, G. Antonelli, 2009, Intervirology.

Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an Italian hospital

G. Antonelli, A. Carattoli, G. Raponi, 2020, International Journal of Antimicrobial Agents.

Antigen presentation by specifically sensitized macrophages in interferon-γ induction

G. Antonelli, F. Dianzani, 1986 .

New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase.

E. De Clercq, R. Pauwels, G. Antonelli, 1996, Antiviral research.

Mechanism of human interferon-? production: Involvement of ?-2-microglobulin

G. Antonelli, F. Dianzani, F. Malavasi, 1988 .

Influence of monoclonal antibodies against HLA class I and class II antigen on interferon-γ and -α induction

G. Antonelli, F. Dianzani, F. Malavasi, 1987 .

Anti-HIV Antiviral Activity of Stavudine in a Thymidine Kinase-Deficient Cellular Line

O. Turriziani, G. Antonelli, F. Dianzani, 1998, Antiviral therapy.

Zidovudine induces the expression of cellular resistance affecting its antiviral activity.

O. Turriziani, G. Antonelli, F. Dianzani, 1994, AIDS research and human retroviruses.

Increased IL-17 and/or IFN-&ggr; producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women

C. Scagnolari, G. Antonelli, E. N. Cavallari, 2019, AIDS.

Bronchiolitis: Analysis of 10 consecutive epidemic seasons

C. Scagnolari, A. Pierangeli, G. Antonelli, 2016, Pediatric pulmonology.

Variation in interferon sensitivity and induction between Usutu and West Nile (lineages 1 and 2) viruses.

A. la Sala, C. Scagnolari, G. Antonelli, 2015, Virology.

Usutu virus growth in human cell lines: induction of and sensitivity to type I and III interferons.

C. Scagnolari, G. Antonelli, P. Villari, 2013, The Journal of general virology.

Pandemic 2009 H1N1 influenza virus is resistant to the antiviral activity of several interferon alpha subtypes.

C. Scagnolari, O. Turriziani, K. Monteleone, 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

In vitro sensitivity of human metapneumovirus to type I interferons.

C. Scagnolari, K. Monteleone, A. Pierangeli, 2011, Viral immunology.

Rhinovirus species/genotypes and interferon-λ: subtypes, receptor and polymorphisms – missing pieces of the puzzle of childhood asthma?

C. Scagnolari, A. Pierangeli, G. Antonelli, 2017, European Respiratory Journal.

Interferon-induced antiviral actions in Friend leukemia cells: role of membrane gangliosides.

G. Antonelli, F. Belardelli, G. D'agnolo, 1982, Virology.

Effects of Interferon-α Treatment on Neutrophil Oxidative Metabollsm, Lymphocyte Prollferation and Monocyte HLA Class I Antigen Expression in Patients with Chronic Hepatitis C

G. Antonelli, G. Giannelli, O. Schiraldi, 1996 .

Polymorphic effects of exogenous gangliosides on antigen-induced lymphoproliferation and generation of MHC unrestricted cell mediated cytotoxicity.

G. Antonelli, C. Casciani, C. Amici, 1990, International journal of immunopharmacology.

Rhinovirus frequently detected in elderly adults attending an emergency department

C. Scagnolari, A. Pierangeli, G. Antonelli, 2011, Journal of medical virology.

Seroprevalence of group B Coxsackieviruses: Retrospective study in an Italian population

O. Turriziani, G. Antonelli, G. Giannelli, 2020, Journal of medical virology.

Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2

O. Turriziani, G. Antonelli, M. Capobianchi, 2001, AIDS.

Early Steps in Interferon-γ Production: Possible Involvement of Ca2+-CalmodulinDependent Enzymes

G. Antonelli, F. Dianzani, V. Ruggiero, 1988 .

Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study

S. Merler, F. Trentini, G. Antonelli, 2022, Frontiers in Immunology.

In vivo development of antibody to interferons: an update to 1996.

G. Antonelli, 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Redondovirus DNA in human respiratory samples

O. Turriziani, G. Antonelli, M. Pistello, 2020, Journal of Clinical Virology.

Low prevalence of Gemycircularvirus DNA in immunocompetent and immunocompromised subjects.

G. Antonelli, M. Pistello, F. Falasca, 2019, The New Microbiologica.

Neutralizing and Binding Antibodies to IFN-β: Relative Frequency in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different IFN-β Preparations

V. Tomassini, C. Scagnolari, O. Turriziani, 2002 .

Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-beta preparations.

V. Tomassini, C. Scagnolari, O. Turriziani, 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-α.

C. Scagnolari, G. Antonelli, G. Giannelli, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Reflections on the immunogenicity of therapeutic proteins.

G. Antonelli, Guido Antonelli, 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Cystic lymphoepithelial lesions of the parotid gland in HIV-1 infection.

S. Uccini, G. Antonelli, L. Ruco, 2000, AIDS patient care and STDs.

The benign cystic lymphoepithelial lesion of the parotid gland is a viral reservoir in HIV type 1-infected patients.

S. Uccini, G. Antonelli, A. Angeloni, 1999, AIDS research and human retroviruses.

Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals.

G. Ippolito, G. Antonelli, 2016, Clinical Microbiology and Infection.

Recently described innate broad spectrum virus inhibitors☆

G. Antonelli, F. Dianzani, A. Chopra, 1989, Microbial Pathogenesis.

Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation

R. Brandi, O. Turriziani, G. Antonelli, 2022, Clinical Microbiology and Infection.

Replication of human immunodeficiency virus: yield of infectious virus under single growth cycle conditions

G. Antonelli, M. Capobianchi, F. Dianzani, 2005, Archives of Virology.

Infectious virus with reduced cytopathogenicity resulting from persistent infection of normal lung fibroblasts by HIV type 1 strains.

G. Antonelli, F. Dianzani, A. Toniolo, 1994, AIDS research and human retroviruses.

Prostaglandin A inhibits replication of human immunodeficiency virus during acute infection.

O. Turriziani, G. Antonelli, H. Ankel, 1991, The Journal of general virology.

Susceptibility of human immunodeficiency virus to antiviral agents measured by infectious virus yield reduction.

G. Antonelli, M. Capobianchi, F. Dianzani, 1989, Antiviral research.

Human bocavirus infection in hospitalized children in Italy

C. Scagnolari, A. Pierangeli, G. Antonelli, 2008, Influenza and other respiratory viruses.

Generation of a soluble IFN-γ inducer by oxidation of galactose residues on macrophages

G. Antonelli, J. Blalock, F. Dianzani, 1985 .

Low incidence of neutralizing antibody formation to interferon-alpha 2b in human recipients.

G. Antonelli, F. Dianzani, P. Amicucci, 1989, Journal of interferon research.

Inhibition of contact sensitivity to oxazolone by the calmodulin inhibitor trifluoroperazine.

G. Antonelli, F. Dianzani, M. Santiano, 1987, International journal of immunopharmacology.

SARS-CoV-2 infection: diagnostic testing results occasionally require special attention

O. Turriziani, G. Antonelli, G. Patti, 2020, Emerging microbes & infections.

A BRIEF COMMUNICATION

C. Scagnolari, A. Pierangeli, G. Antonelli, 2007 .

Probiotic supplementation promotes a reduction in T‐cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART‐treated HIV‐1‐positive patients

G. Rossi, J. Brenchley, C. Scagnolari, 2017, Immunity, inflammation and disease.

A BRIEF COMMUNICATION

C. Scagnolari, A. Pierangeli, G. Antonelli, 2007, Experimental biology and medicine.

Quantitative HIV-1 proviral DNA detection: a multicentre analysis.

C. Scagnolari, G. Antonelli, L. Buonaguro, 2010, The new microbiologica.

Susceptibility Testing of Colistin for Acinetobacter baumannii: How Far Are We from the Truth?

G. Antonelli, P. Visca, G. Raponi, 2021, Antibiotics.

Molecular epidemiology and genetic diversity of human rhinovirus affecting hospitalized children in Rome

C. Scagnolari, A. Pierangeli, G. Antonelli, 2013, Medical Microbiology and Immunology.

Neutralizing Antibodies to Interferon-α: Relative Frequency in Patients Treated with Different Interferon Preparations

O. Turriziani, G. Antonelli, F. Dianzani, 1991, The Journal of infectious diseases.

Occult hepatitis C virus infection in type II mixed cryoglobulinaemia

C. Scagnolari, G. Antonelli, M. Fiorilli, 2003, Journal of viral hepatitis.

Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy.

G. Antonelli, A. Aiuti, F. Ficara, 2000, AIDS research and human retroviruses.

Screening, monitoring, prevention, prophylaxis and therapy for hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation: a systematic review.

G. Antonelli, M. Andreoni, L. Sarmati, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review

G. Antonelli, G. Gentile, 2019, Viruses.

Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation-a position paper.

R. Bruno, G. Antonelli, C. Perno, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Induction of the multidrug-transporter P-glycoprotein by 3'-azido-3'-deoxythymidine (AZT) treatment in tumor cell lines.

O. Turriziani, G. Antonelli, F. Dianzani, 1997, Journal of experimental & clinical cancer research : CR.

Further study of the mechanism underlying the cellular resistance to AZT.

O. Turriziani, G. Antonelli, F. Dianzani, 1996, Biochemical and biophysical research communications.

Alteration of thymidine kinase activity in cells treated with an antiviral agent.

O. Turriziani, G. Antonelli, V. Tozzi, 1995, Journal of biological regulators and homeostatic agents.

Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020

S. Rubino, P. Fontana, E. Lavezzo, 2022, Scientific reports.

Hepatitis C virus present in the sera of infected patients interferes with the autophagic process of monocytes impairing their in-vitro differentiation into dendritic cells.

G. Antonelli, L. Frati, M. Cirone, 2014, Biochimica et biophysica acta.

Common Microbial Genital Infections and Their Impact on the Innate Immune Response to HPV in Cervical Cells

C. Scagnolari, A. Pierangeli, G. Antonelli, 2022, Pathogens.

Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women.

C. Scagnolari, A. Pierangeli, G. Antonelli, 2007, Clinical Microbiology and Infection.

Direct sequencing of HPV DNA detected in gynaecologic outpatients in Rome, Italy.

A. Pierangeli, G. Antonelli, M. Bucci, 2006, Microbes and infection.

Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients

A. Lazzarin, O. Turriziani, G. Antonelli, 2005, AIDS.

90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection.

S. Iacobelli, G. Antonelli, F. Dianzani, 1993, Journal of acquired immune deficiency syndromes.

Interferon-Induced Gene Expression in Cervical Mucosa during Human Papillomavirus Infection

C. Scagnolari, O. Turriziani, A. Pierangeli, 2011, International journal of immunopathology and pharmacology.

Pharmacokinetics of recombinant interferon-alpha 2 following intralesional administration in malignant glioma patients.

A. Maleci, G. Antonelli, F. Dianzani, 1987, Journal of interferon research.

Candida blood stream infections observed between 2011 and 2016 in a large Italian University Hospital: A time-based retrospective analysis on epidemiology, biofilm production, antifungal agents consumption and drug-susceptibility

A. Giuliani, G. Antonelli, G. Raponi, 2019, PloS one.

Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection

C. Scagnolari, G. Antonelli, G. d’Ettorre, 2020, Medicine.

Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro

C. Scagnolari, A. Pierangeli, G. Antonelli, 2020, Pharmacological Research.

Reflections after 2 years of COVID‐19 pandemic

A. Casadevall, G. Antonelli, D. Focosi, 2022, Reviews in medical virology.

COVID-19 infodemics: the role of mainstream and social media

G. Antonelli, E. Roilides, D. Focosi, 2021, Clinical Microbiology and Infection.

Antiviral therapy: old and current issues.

O. Turriziani, G. Antonelli, 2012, International journal of antimicrobial agents.

Human Gyrovirus DNA in Human Blood, Italy

U. Boggi, G. Antonelli, M. Pistello, 2012, Emerging infectious diseases.

Novel variants of respiratory syncytial virus A ON1 associated with increased clinical severity of bronchiolitis.

C. Scagnolari, A. Pierangeli, G. Antonelli, 2020, The Journal of infectious diseases.

Respiratory syncytial virus bronchiolitis, weather conditions and air pollution in an Italian urban area: An observational study

C. Scagnolari, A. Pierangeli, G. Antonelli, 2017, Environmental Research.

Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus

C. Scagnolari, K. Monteleone, A. Pierangeli, 2012, Medical Microbiology and Immunology.

Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, Italy

C. Scagnolari, A. Pierangeli, G. Antonelli, 2007, Journal of medical virology.

Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19

G. Rossi, C. Scagnolari, G. Antonelli, 2020, Frontiers in Medicine.

Assessment of prevalence and load of torquetenovirus viremia in a large cohort of healthy blood donors.

S. Salvadori, G. Antonelli, M. Pistello, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Prenatal diagnosis of fetal cytomegalovirus infection after primary or recurrent maternal infection.

G Nigro, G Antonelli, G. Antonelli, 1999, Obstetrics and gynecology.

Cyclovirus Vietnam DNA in immunodeficient patients.

G. Antonelli, M. Pistello, A. Manzin, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Interferon lambda 1 expression in cervical cells differs between low-risk and high-risk human papillomavirus-positive women

C. Scagnolari, A. Pierangeli, G. Antonelli, 2014, Medical Microbiology and Immunology.

[Role of gangliosides in interferon and cell membrane interaction].

G. Antonelli, F. Belardelli, G. D'agnolo, 1982, Annali dell'Istituto superiore di sanita.

Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients

A. Folgori, C. Scagnolari, G. Antonelli, 2009, Medical Microbiology and Immunology.

Selection of a T-Cell Line Resistant to Stavudine and Zidovudine by Prolonged Treatment with Stavudine

C. Scagnolari, O. Turriziani, G. Antonelli, 2001, Antiviral therapy.

The effects of prolonged treatment with zidovudine, lamivudine, and abacavir on a T-lymphoblastoid cell line.

O. Turriziani, A. Pierangeli, G. Antonelli, 2006, AIDS research and human retroviruses.

Lack of reduction of thymidine kinase activity in stavudine-treated HIV-infected patients.

A. Lazzarin, O. Turriziani, G. Antonelli, 2004, AIDS Research and Human Retroviruses.

Cellular issues relating to the resistance of HIV to antiretroviral agents

C. Scagnolari, O. Turriziani, G. Antonelli, 2003, Scandinavian journal of infectious diseases. Supplementum.

Cellular factors involved in the induction of resistance of HIV to antiretroviral agents.

O. Turriziani, G. Antonelli, F. Dianzani, 2000, International journal of antimicrobial agents.

In vitro Selection of Human Immunodeficiency Virus Type 1 Resistant to Ro 31-8959 Proteinase Inhibitor

O. Turriziani, G. Antonelli, E. Riva, 1993 .

Thymidine kinase and deoxycytidine kinase in HIV-infected children.

O. Turriziani, G. Antonelli, F. Falasca, 2009, The new microbiologica.

Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies

L. Kappos, C. Scagnolari, G. Antonelli, 2007, Journal of Neurology.

Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response to antiviral treatment.

C. Scagnolari, O. Turriziani, G. Antonelli, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Future management of viral diseases: role of new technologies and new approaches in microbial interactions.

F Maggi, M Pistello, G Antonelli, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Twenty-five years of type I interferon-based treatment: A critical analysis of its therapeutic use

C. Scagnolari, G. Antonelli, E. Proietti, 2014, Cytokine & Growth Factor Reviews.

Approval Standards for Alfa Interferon Subtypes

B. Williams, G. Antonelli, R. Spiegel, 2000 .

Development of neutralizing and binding antibodies to interferon (IFN) in patients undergoing IFN therapy.

G. Antonelli, Guido Antonelli, 1994, Antiviral research.

Breakthrough in Chronic Hepatitis C During Recombinant Alpha Interferon Therapy

G. Mancia, G. Antonelli, F. Dianzani, 1994 .

Antibodies to interferon alpha in patients.

G. Antonelli, F. Dianzani, Guido Antonelli, 1993, Archives of virology. Supplementum.

Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia.

G. Antonelli, F. Dianzani, L. Bonomo, 1991, Blood.

What is the Practical Significance of Antibodies to Interferons?

G. Antonelli, F. Dianzani, 1998, BioDrugs.

Development of Neutralizing Antibodies in Patients with Relapsing-Remitting Multiple Sclerosis Treated with IFN-β1a

C. Pozzilli, G. Antonelli, C. Gasperini, 1998 .

Pharmacokinetics of recombinant interferon (IFN)-α in a hepatitis patient with neutralizing antibody to IFN

O. Turriziani, G. Antonelli, F. Dianzani, 1997 .

Fate of antibody to interferon (IFN) in chronic hepatitis C patients treated with recombinant IFN alpha 2 and retreated with lymphoblastoid IFN alpha

G. Antonelli, G. Giannelli, O. Schiraldi, 1995 .

Biological basis for a proper clinical application of alpha interferons.

G. Antonelli, 2008, The new microbiologica.

Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b

C. Pozzilli, O. Turriziani, G. Antonelli, 1999, Journal of the Neurological Sciences.

Clinical significance of recombinant interferon-alpha 2 neutralizing antibodies in hepatitis patients.

G. Antonelli, G. Giannelli, F. Dianzani, 1994, Journal of interferon research.

Dynamics of Persistent TT Virus Infection, as Determined in Patients Treated with Alpha Interferon for Concomitant Hepatitis C Virus Infection

G. Antonelli, M. Pistello, M. Bendinelli, 2001, Journal of Virology.

Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: Prevalence, etiology, and management

G. Mancia, G. Antonelli, D. Ravizza, 1995 .

Synthesis and antiviral properties of 9-[(2-methyleneaminoxyethoxy)methyl]guanine derivatives as novel Acyclovir analogues.

O. Turriziani, G. Antonelli, E. Orlandini, 2000, Farmaco.

MxA and PKR expression in chronic hepatitis C.

G. Antonelli, G. Giannelli, S. Antonaci, 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Synthesis and antiviral properties of novel analogues of monophosphate and diphosphate bioactive forms of acyclovir.

O. Turriziani, G. Antonelli, S. Bertini, 2000, Farmaco.

Localization of hepatitis C virus in gastrointestinal mucosa: A possible reservoir for relapse

G. Antonelli, E. Riva, L. Miglioresi, 2003, Hepatology.

The combined treatment of human peripheral blood mononuclear cells with thymolymphotropin and interleukin 2 increases PPD-driven T-cell proliferation and IL-2 induced cellular cytotoxicity against HIV-infected cells.

G. Antonelli, A. D. Di Massimo, M. Bardone, 1991, International journal of immunopharmacology.

Host factors and efficacy of antiretroviral treatment.

O. Turriziani, G. Antonelli, 2004, The new microbiologica.

Antibiotic Resistance and Therapy for H. pylori Infection in Immigrant Patients Treated in Italy

A. Zullo, G. Antonelli, T. Lazzarotto, 2020, Journal of clinical medicine.

Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha

C. Scagnolari, G. Antonelli, C. Selvaggi, 2010, Virology Journal.

Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus–infected liver tissue

G. Antonelli, I. Pacella, E. Timperi, 2014, Hepatology.

Generation and characterization of cytotoxic activity against tumor cell lines in human peripheral blood mononuclear cells stimulated "in vitro" by a glucomannan-protein preparation of Candida albicans.

G. Antonelli, F. Dianzani, F. Malavasi, 1987, Journal of biological regulators and homeostatic agents.

CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats

O. Turriziani, G. Antonelli, J. Heeney, 2021, Journal of virology.

The HIV-1 provirus excised by a single CRISPR/Cas9 RNA guide persists in the host cell and may be reactivated

O. Turriziani, G. Antonelli, J. Heeney, 2020, bioRxiv.

Potential IFNγ Modulation of Inflammasome Pathway in Chlamydia trachomatis Infected Synovial Cells

C. Scagnolari, G. Antonelli, R. Sessa, 2021, Life.

Serum Interferon (IFN)-Neutralizing Antibodies and Bioactivities of IFNs in Patients with Severe Type II Essential Mixed Cryoglobulinemia

C. Scagnolari, O. Turriziani, G. Antonelli, 2003, Clinical Diagnostic Laboratory Immunology.

MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients

C. Scagnolari, O. Turriziani, K. Monteleone, 2015, BMC Infectious Diseases.

TLR9 is expressed in human papillomavirus-positive cervical cells and is overexpressed in persistent infections.

C. Scagnolari, A. Pierangeli, G. Antonelli, 2015, Immunobiology.

SARS-CoV-2 diagnostics: Some reflections on current assays

G. Antonelli, M. Pistello, S. Stefani, 2020, Diagnostic Microbiology and Infectious Disease.

Predicting beta-interferon failure in relapsing-remitting multiple sclerosis

G. Antonelli, M. Hutchinson, C. Walsh, 2007, Multiple sclerosis.

Discordant effect of IFN-beta1a therapy on anti-IFN antibodies and thyroid disease development in patients with multiple sclerosis.

L. Murri, C. Scagnolari, G. Antonelli, 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Yersinia enterocolitica in Italy: A Case of Septicemia and Abdominal Aortic Aneurysm Infection

G. Antonelli, F. Speziale, A. Bressan, 2018, Front. Med..

IFN-stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1 infection

C. Scagnolari, O. Turriziani, K. Monteleone, 2016, Archives of Virology.

Merkel Cell Polyomavirus DNA Detection in Respiratory Samples: Study of a Cohort of Patients Affected by Cystic Fibrosis

G. Antonelli, C. De Vito, M. Trancassini, 2019, Viruses.

Evaluation of interleukin 28B single nucleotide polymorphisms in infants suffering from bronchiolitis

C. Scagnolari, K. Monteleone, A. Pierangeli, 2012, Virus Research.

The number of HIV DNA-infected mononuclear cells is reduced under HAART plus recombinant IL-2. IRHAN Study Group.

O. Turriziani, G. Antonelli, M. Capobianchi, 2000, Antiviral research.

Diagnosis; Future Prospects on Direct Diagnosis

G. Antonelli, F. Maggi, D. Di Carlo, 2021, Encyclopedia of Virology.

Molecular diagnosis of SARS-CoV-2 in seminal fluid

O. Turriziani, G. Antonelli, A. Lenzi, 2021, Journal of Endocrinological Investigation.

Susceptibility of human and non-human cell lines to HCV infection as determined by the centrifugation-facilitated method.

G. Antonelli, M. Pistello, M. Bendinelli, 1999, Journal of virological methods.

Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants

D. De Angelis, C. Scagnolari, A. Pierangeli, 2009, Archives of Disease in Childhood.

Cytomegalovirus in Bone Marrow Cells Correlates with Cytomegalovirus in Peripheral Blood Leukocytes

R. Foà, G. Antonelli, A. Testi, 2014, Journal of Clinical Microbiology.

Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020

S. Rubino, P. Fontana, E. Lavezzo, 2021, Scientific Reports.

Clinical effects of interferon in patients with idiopathic mixed cryoglobulinemia

G. Antonelli, F. Dianzani, B. Laganà, 1990, European journal of haematology. Supplementum.

Dominant enrichment of phenotypically activated CD38+HLA‐DR+CD8+ T cells, rather than CD38+HLA‐DR+CD4+ T cells, in HIV/HCV coinfected patients on antiretroviral therapy

O. Turriziani, G. Antonelli, E. N. Cavallari, 2016, Journal of medical virology.

The Synergistic Interaction of Interferon Types I and II Leads to Marked Reduction in Severe Acute Respiratory Syndrome-Associated Coronavirus Replication and Increase in the Expression of mRNAs for Interferon-Induced Proteins

C. Scagnolari, G. Antonelli, M. Clementi, 2006, Intervirology.

KI and WU Polyomavirus in Respiratory Samples of SARS-CoV-2 Infected Patients

C. Scagnolari, O. Turriziani, A. Pierangeli, 2021, Microorganisms.

Ebolavirus and evidence-based speculations.

G. Antonelli, D. Focosi, F. Maggi, 2016, The new microbiologica.

Resistant viral variants in cellular reservoirs of human immunodeficiency virus infection.

O. Turriziani, G. Antonelli, M. Andreoni, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Mutational resistance pattern of HIV type 1 in CD14+ monocytes, CD4+ T cells, and plasma from treated patients.

O. Turriziani, G. Antonelli, G. d’Ettorre, 2010, AIDS research and human retroviruses.

Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive?

O. Turriziani, G. Antonelli, F. Falasca, 2020, Journal of Clinical Virology.

Inhibition of HIV Type 1 BaL Replication by MIP-lα, MIP-1β, and RANTES in Macrophages

O. Turriziani, G. Antonelli, M. Capobianchi, 1998 .

Inhibition of HIV type 1 BaL replication by MIP-1alpha, MIP-1beta, and RANTES in macrophages.

O. Turriziani, G. Antonelli, M. Capobianchi, 1998, AIDS research and human retroviruses.

P-Glycoprotein Expression by Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected Patients Is Independent from Response to Highly Active Antiretroviral Therapy

C. Agrati, S. Topino, P. Narciso, 2003, Clinical Diagnostic Laboratory Immunology.

Incidence and predisposing factors for severe disease in previously healthy term infants experiencing their first episode of bronchiolitis

Fabio Midulla, Corrado Moretti, Paola Papoff, 2011, Acta paediatrica.

Gene Expression of Nucleic Acid-Sensing Pattern Recognition Receptors in Children Hospitalized for Respiratory Syncytial Virus-Associated Acute Bronchiolitis

D. De Angelis, C. Scagnolari, A. Pierangeli, 2009, Clinical and Vaccine Immunology.

Increased autoreactive T cell frequency in tuberculous patients.

G. Antonelli, P. Del Porto, G. Lombardi, 1990, International archives of allergy and applied immunology.

Lack of usutu virus RNA in cerebrospinal fluid of patients with encephalitis of unknown etiology, Tuscany, Italy

C. Scagnolari, G. Antonelli, A. Manzin, 2015, Journal of medical virology.

Study of the genotypic resistant pattern in HIV-infected women and children from rural west Cameroon.

O. Turriziani, G. Antonelli, V. Vullo, 2008, AIDS research and human retroviruses.

Induction of Alpha Interferon by Membrane Interaction between Viral Surface and Peripheral Blood Mononuclear Cells

G. Antonelli, M. Capobianchi, F. Dianzani, 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity

C. Scagnolari, A. Pierangeli, G. Antonelli, 2023, Microorganisms.

Genotypic Resistance of Archived and Circulating Viral Strains in the Blood of Treated HIV-Infected Individuals

C. Scagnolari, O. Turriziani, G. Antonelli, 2007, Journal of acquired immune deficiency syndromes.

Immunodeficiency-associated viral oncogenesis.

A. Pierangeli, G. Antonelli, G. Gentile, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Diagnosis of anal human papillomavirus infection: polymerase chain reaction or cytology?

G. Antonelli, G. d’Ettorre, V. Vullo, 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy.

O. Turriziani, G. Antonelli, V. Tozzi, 2001, AIDS research and human retroviruses.

Is human immunodeficiency virus RNA load composed of neutralized immune complexes?

O. Turriziani, G. Antonelli, F. Dianzani, 2002, The Journal of infectious diseases.

Measurement of the sensitivity of different commercial assays in the diagnosis of CMV infection in pregnancy

G. Antonelli, C. Galli, P. Pagnotti, 2009, European Journal of Clinical Microbiology & Infectious Diseases.

Is hepatitis C virus eradication around the corner only 25 years after its discovery?

G. Ippolito, G. Antonelli, M. Capobianchi, 2015, International journal of antimicrobial agents.

Assessment of Anxiety, Depression, Work-Related Stress, and Burnout in Health Care Workers (HCWs) Affected by COVID-19: Results of a Case–Control Study in Italy

G. Antonelli, G. La Torre, C. Ajassa, 2022, Journal of clinical medicine.

Antiviral Activity of the Combination of Interferon and Ribavirin Against Chikungunya Virus: Are the Results Conclusive?

C. Scagnolari, G. Antonelli, B. Caputo, 2016, The Journal of infectious diseases.

Pharmacodynamics of peginterferon alpha-2a and peginterferon alpha-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled study.

R. Bruno, G. Filice, C. Scagnolari, 2007, Alimentary pharmacology & therapeutics.

The Absence of HIV Mutations in Cerebrospinal Fluid and in Peripheral Blood Mononuclear Cells During a Regimen Containing Trizivir Plus Tenofovir

O. Turriziani, G. Antonelli, G. d’Ettorre, 2009, Journal of chemotherapy.

Analysis of Th17 and Tc17 Frequencies and Antiviral Defenses in Gut-Associated Lymphoid Tissue of Chronic HIV-1 Positive Patients

C. Scagnolari, G. Antonelli, G. d’Ettorre, 2015, Mediators of inflammation.

Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART.

G. Antonelli, M. Marziali, M. Pierdominici, 2000, Clinical immunology.

A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA‐29a‐c levels in antiretroviral‐treated HIV‐1‐infected patients

C. Scagnolari, G. Antonelli, G. d’Ettorre, 2017, Brain and behavior.

Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus viremia, the new surrogate marker of immune competence

G. Antonelli, M. Pistello, R. Danesi, 2019, Journal of medical virology.

Cell mediated cytotoxicity and cytokine production in peripheral blood mononuclear cells of glioma patients.

A. Maleci, G. Antonelli, C. Amici, 1991, European journal of cancer.

Cell-mediated cytotoxicity in glioma-bearing patients: Differential responses of peripheral blood mononuclear cells to stimulation with interleukin-2 and microbial antigen

A. Maleci, G. Antonelli, A. Cassone, 1988, Journal of Neuro-Oncology.

High-performance liquid chromatographic approach to the separation of antiviral and immunostimulant fractions in Neuramide.

G. Antonelli, B. Rindone, P. Amicucci, 1990, Journal of chromatography.

Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years

V. Tomassini, C. Pozzilli, C. Scagnolari, 2003, Journal of the Neurological Sciences.

Susceptibility towards Chickenpox, Measles and Rubella among Healthcare Workers at a Teaching Hospital in Rome

G. Antonelli, G. La Torre, A. Gaeta, 2022, Vaccines.

Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes.

A. Farcomeni, G. Antonelli, A. Aceti, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy

C. Scagnolari, A. Pierangeli, G. Antonelli, 2020, Journal of Cystic Fibrosis.

Torque teno virus (TTV): A gentle spy virus of immune status, predictive marker of seroconversion to COVID‐19 vaccine in kidney and lung transplant recipients

G. Antonelli, F. Venuta, C. Carillo, 2023, Journal of Medical Virology.

Investigation on torquetenovirus (TTV) microRNA transcriptome in vivo.

G. Antonelli, M. Pistello, S. Giannecchini, 2016, Virus research.

Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients

C. Scagnolari, G. Antonelli, E. Albert, 2018, Scientific Reports.

Lack of Marseillevirus DNA in immunocompetent and immunocompromised Italian patients

G. Antonelli, M. Pistello, D. Focosi, 2020, Journal of medical virology.

SARS‐CoV‐2 diagnostics in the virology laboratory of a University Hospital in Rome during the lockdown period

O. Turriziani, G. Antonelli, A. Carattoli, 2020, Journal of medical virology.

Interferon-γ Possesses Anti-Microbial and Immunomodulatory Activity on a Chlamydia trachomatis Infection Model of Primary Human Synovial Fibroblasts

C. Scagnolari, G. Antonelli, R. Sessa, 2020, Microorganisms.

Modulation of Phenylalanine and Tyrosine Metabolism in HIV-1 Infected Patients with Neurocognitive Impairment: Results from a Clinical Trial

C. Scagnolari, G. Antonelli, E. N. Cavallari, 2020, Metabolites.

C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection.

O. Turriziani, G. Antonelli, A. Mazzone, 1997, Journal of immunology.

IN VITRO ASSESSMENT OF THE BIOLOGIC ACTIVITY OF INTERFERON BETA FORMULATIONS USED FOR THE TREATMENT OF RELAPSING MULTIPLE SCLEROSIS

C. Scagnolari, G. Antonelli, C. Selvaggi, 2014, Journal of immunoassay & immunochemistry.

Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns

O. Turriziani, G. Antonelli, G. d’Ettorre, 2017, BMC Infectious Diseases.

Virology: a scientific discipline facing new challenges.

M Pistello, G Antonelli, G. Antonelli, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Rapid spread of the novel respiratory syncytial virus A ON1 genotype, central Italy, 2011 to 2013.

C. Scagnolari, A. Pierangeli, G. Antonelli, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Anosmia and Ageusia as Predictive Signs of COVID-19 in Healthcare Workers in Italy: A Prospective Case-Control Study

O. Turriziani, G. Antonelli, G. La Torre, 2020, Journal of clinical medicine.

Rhinovirus bronchiolitis and recurrent wheezing: 1-year follow-up

E. Bonci, C. Scagnolari, A. Pierangeli, 2011, European Respiratory Journal.

Type-specific human papillomavirus-DNA load in anal infection in HIV-positive men

C. Scagnolari, A. Pierangeli, G. Antonelli, 2008, AIDS.

Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature.

O. Turriziani, G. Antonelli, M. Venditti, 2022, The new microbiologica.

Evaluation of performances of VERSANT HCV RNA 1.0 assay (kPCR) and Roche COBAS AmpliPrep/COBAS TaqMan HCV test v2.0 at low level viremia.

O. Turriziani, G. Antonelli, F. Falasca, 2016, The new microbiologica.

Predictors of long–term clinical response to interferon beta therapy in relapsing multiple sclerosis

V. Tomassini, C. Pozzilli, G. Antonelli, 2006, Journal of Neurology.

What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?

G. Antonelli, M. Tuccori, D. Focosi, 2020, Clinical Microbiology and Infection.

TRANSMITTED DRUG RESISTANCE MUTATIONS AND TRENDS OF HIV-1 SUBTYPES IN TREATMENT-NAÏVE PATIENTS: A SINGLE CENTER EXPERIENCE.

O. Turriziani, G. Antonelli, G. d’Ettorre, 2020, Journal of global antimicrobial resistance.

Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients

C. Scagnolari, O. Turriziani, A. Pierangeli, 2023, Microorganisms.

Synthesis and HIV-1 inhibitory properties of new tetrahydrobenzoquinazolinedione and tetrahydrobenzocycloheptenuracil derivatives and of their thioxo analogues.

O. Turriziani, G. Antonelli, A. Martinelli, 1999, Farmaco.

Cellmediatedcytotoxicity and cytokineproduction in peripheralbloodmononuclearcells of gliomapatients

A. Maleci, G. Antonelli, C. Amici, 1991 .

Induction of human immune interferon with ionophores.

G. Antonelli, M. Capobianchi, F. Dianzani, 1986, Methods in enzymology.

Membrane Events Leading to Interferon-γ Induction by Antigens

G. Antonelli, M. Capobianchi, F. Dianzani, 1985 .

Xenotropic murine leukaemia virus-related virus is not found in peripheral blood cells from treatment-naive human immunodeficiency virus-positive patients.

G. Antonelli, M. Pistello, D. Focosi, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Modifications of HIV-1 DNA and Provirus-Infected Cells During 24 Months of Intermittent Highly Active Antiretroviral Therapy

G. Antonelli, L. Palmisano, F. Chiarotti, 2008, Journal of acquired immune deficiency syndromes.

Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage regimen: 72-week follow-up.

O. Turriziani, G. Antonelli, M. Bucci, 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Short communication: analysis of the integrase gene from HIV type 1-positive patients living in a rural area of West Cameroon.

O. Turriziani, G. Antonelli, V. Vullo, 2012, AIDS research and human retroviruses.

ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry?

C. Scagnolari, A. Pierangeli, G. Antonelli, 2021, Cytokine.

How Respiratory Syncytial Virus Genotypes Influence the Clinical Course in Infants Hospitalized for Bronchiolitis

C. Scagnolari, A. Pierangeli, G. Antonelli, 2018, The Journal of infectious diseases.

Detection and quantification of EBV, HHV-6 and CMV DNA in the gastrointestinal tract of HIV-positive patients

O. Turriziani, G. Antonelli, C. Castilletti, 2014, Infection.

Interferon-β 1a inhibits SARS-CoV-2 in vitro when administered after virus infection.

C. Scagnolari, G. Antonelli, Nicola Clementi, 2020, The Journal of infectious diseases.

Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome–Coronavirus 2 In Vitro When Administered After Virus Infection

C. Scagnolari, G. Antonelli, Nicola Clementi, 2020, The Journal of Infectious Diseases.

MALDI-TOF MS Versus VITEK®2: Comparison of Systems for the Identification of Microorganisms Responsible for Bacteremia

G. Antonelli, M. Trancassini, V. Pietropaolo, 2016, Current Microbiology.

High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients.

C. Scagnolari, G. Antonelli, G. d’Ettorre, 2020, AIDS.

Neutralizing and Binding Antibodies to Interferon Beta in Patients with Multiple Sclerosis: A Comparison of Assay Results from Three Italian Centres

C. Scagnolari, G. Antonelli, M. Trojano, 2008, Journal of immunoassay & immunochemistry.

Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue

C. Scagnolari, G. Antonelli, D. Duffy, 2020, Frontiers in Immunology.

Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection.

A. Zullo, G. Antonelli, T. Lazzarotto, 2020, European journal of internal medicine.

P-glycoprotein expression affects the intracellular concentration and antiviral activity of the protease inhibitor saquinavir in a T cell line.

C. Scagnolari, O. Turriziani, G. Antonelli, 2004, The New Microbiologica.

A one-year study on the pharmacodynamic profile of interferon-beta1a in MS.

P. Pasqualetti, C. Pozzilli, C. Scagnolari, 2002, Neurology.

Why do infections cause cancer?

G. Antonelli, G. Spagnoli, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The Synergistic Effect of Time of Exposure, Distance and No Use of Personal Protective Equipment in the Determination of SARS-CoV-2 Infection: Results of a Contact Tracing Follow-Up Study in Healthcare Workers

O. Turriziani, G. Antonelli, G. La Torre, 2021, International journal of environmental research and public health.

ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response.

C. Scagnolari, O. Turriziani, K. Monteleone, 2016, Immunobiology.

Viral Load in Infants Hospitalized for Respiratory Syncytial Virus Bronchiolitis Correlates with Recurrent Wheezing at Thirty-Six-Month Follow-Up

C. Scagnolari, A. Pierangeli, G. Antonelli, 2015, The Pediatric infectious disease journal.

Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus

C. Scagnolari, K. Monteleone, A. Pierangeli, 2012, Medical Microbiology and Immunology.

Neutralizing antibodies explain the poor clinical response to Interferon beta in a small proportion of patients with Multiple Sclerosis: a retrospective study

V. Tomassini, C. Pozzilli, G. Antonelli, 2009, BMC neurology.

Development of antibodies to interferon beta in patients: technical and biological aspects.

G. Antonelli, F. Dianzani, 1999, European cytokine network.

Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators

O. Turriziani, G. Antonelli, J. Hiscott, 2019, Journal of Virology.

Neutralizing antibodies to interferon alpha in a chronic hepatitis C patient non-responder to pegylated interferon.

C. Scagnolari, G. Antonelli, M. Milella, 2006, Journal of hepatology.

Treatment with natural IFN of hepatitis C patients with or without antibodies to recombinant IFN.

O. Turriziani, G. Antonelli, G. Giannelli, 1995, Hepato-gastroenterology.

Multicenter epidemiological investigation and genetic characterization of respiratory syncytial virus and metapneumovirus infections in the pre-pandemic 2018–2019 season in northern and central Italy

E. Pariani, F. Baldanti, A. Pierangeli, 2022, Clinical and Experimental Medicine.

Anti-N SARS-CoV-2 assays for evaluation of natural viral infection

G. Antonelli, A. Angeloni, A. Gaeta, 2023, Journal of immunological methods.

Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab

O. Turriziani, G. Antonelli, M. Capobianchi, 2021, The Lancet Microbe.

Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group

A. d’Arminio Monforte, F. Baldanti, F. Ceccherini‐Silberstein, 2013, Infection.

Collaborative national multicenter for the identification of conversion factors from copies/mL to international units/mL for the normalization of HCMV DNA load.

F. Baldanti, G. Antonelli, M. Capobianchi, 2019, Diagnostic microbiology and infectious disease.

From 'purging' to 'endogenization' of the HIV genome: a new approach to HIV eradication?

G. Antonelli, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Dynamics of HIV DNA and residual viremia in patients treated with a raltegravir-containing regimen.

O. Turriziani, G. Antonelli, F. Falasca, 2015, Journal of acquired immune deficiency syndromes.

Identification of an amino acid substitution involved in the reduction of sensitivity of HIV-1 to an inhibitor of viral proteinase.

O. Turriziani, G. Antonelli, F. Dianzani, 1994, Acta virologica.

Bone Marrow cells and correlates with Cytomegalovirus 1 in Peripheral Blood Leukocytes 2

R. Foà, G. Antonelli, C. Girmenia, 2014 .

High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19

C. Scagnolari, O. Turriziani, A. Pierangeli, 2022, Clinical Immunology.

Significant reduction in HIV-1 plasma viral load but not in proviral infected cells during sub-optimal antiretroviral therapy.

O. Turriziani, G. Antonelli, V. Tozzi, 2000, Journal of biological regulators and homeostatic agents.

Editorial: HBV and lymphoma

G. Antonelli, L. Arcaini, M. Martelli, 2023, Frontiers in Oncology.

Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and -B bronchiolitis before and after pandemic restrictions in Rome.

C. Scagnolari, O. Turriziani, A. Pierangeli, 2023, The Journal of infection.

Nirmatrelvir and COVID-19: development, pharmacokinetics, clinical efficacy, resistance, relapse, and pharmacoeconomics

A. Casadevall, G. Antonelli, S. Shoham, 2023, International Journal of Antimicrobial Agents.

Molecular epidemiology and genetic diversity of human rhinovirus affecting hospitalized children in Rome

C. Scagnolari, A. Pierangeli, G. Antonelli, 2013, Medical Microbiology and Immunology.

Acute bronchiolitis: Influence of viral co‐infection in infants hospitalized over 12 consecutive epidemic seasons

C. Scagnolari, A. Pierangeli, G. Antonelli, 2017, Journal of medical virology.

Evaluation of interleukin 28B single nucleotide polymorphisms in infants suffering from bronchiolitis

C. Scagnolari, K. Monteleone, A. Pierangeli, 2012, Virus Research.

Evaluation of the Factors Associated with Reinfections towards SARS-CoV-2 Using a Case Control Design

G. Antonelli, G. La Torre, C. Mastroianni, 2023, Journal of clinical medicine.

Torquetenovirus: the human virome from bench to bedside.

G. Antonelli, M. Pistello, D. Focosi, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Development of Neutralizing Antibodies in Patients with Relapsing-Remitting Multiple Sclerosis Treated with IFN-β1a

C. Pozzilli, G. Antonelli, C. Gasperini, 1998 .

Comparative analysis of 2 commercial molecular tests for the detection of gastroenteric viruses on stool samples.

O. Turriziani, G. Antonelli, G. Giannelli, 2020, Diagnostic microbiology and infectious disease.

Relative frequency of nonneutralizing antibodies to interferon (IFN) in hepatitis patients treated with different IFN-alpha preparations.

O. Turriziani, G. Antonelli, F. Dianzani, 1992, The Journal of infectious diseases.

Host genetics: deciphering the variability in susceptibility to infections.

G. Antonelli, E. Roilides, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report: Erratum

C. Scagnolari, G. Antonelli, C. Mastroianni, 2020, Medicine.

Synergistic Effect between SARS-CoV-2 Wave and COVID-19 Vaccination on the Occurrence of Mild Symptoms in Healthcare Workers

G. Antonelli, G. La Torre, M. Giffi, 2023, Vaccines.

The in vitro antiviral activity of tumor necrosis factor (TNF) in WISH cells is mediated by IFN-beta induction.

G. Antonelli, F. Dianzani, V. Ruggiero, 1989, Antiviral research.

Role of Interferons in Chronic Hepatitis C Infection.

C. Scagnolari, K. Monteleone, G. Antonelli, 2017, Current drug targets.

A macrophage-derived factor different from interleukin 1 and able to induce interferon-gamma and lymphoproliferation in resting T lymphocytes.

G. Antonelli, F. Dianzani, J. Van Damme, 1988, Cellular immunology.

Generation of a soluble IFN-gamma inducer by oxidation of galactose residues on macrophages.

G. Antonelli, J. Blalock, F. Dianzani, 1985, Cellular immunology.

Hepatitis C virus present in the sera of infected patients interferes with the autophagic process of monocytes impairing their in-vitro differentiation into dendritic cells.

G. Antonelli, L. Frati, M. Cirone, 2014, Biochimica et biophysica acta.

Genome-Based Retrospective Analysis of a Providencia stuartii Outbreak in Rome, Italy: Broad Spectrum IncC Plasmids Spread the NDM Carbapenemase within the Hospital

G. Antonelli, A. Carattoli, G. Raponi, 2023, Antibiotics.

Hepatitis C virus treatment revolution: need for close monitoring.

G. Ippolito, G. Antonelli, M. Capobianchi, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Treatment of SARS with human interferons

C. Scagnolari, G. Antonelli, E. Vicenzi, 2003, The Lancet.

The SARS-CoV-2 epidemic: how the Italian public is being informed

G. Antonelli, M. Capobianchi, E. Riva, 2020, Clinical Microbiology and Infection.

Resistance to recombinant alpha interferon therapy in idiopathic mixed cryoglobulinemia: reinduction of remission by natural alpha interferon both in antibody-positive and -negative patients.

L. Pucillo, G. Antonelli, F. Dianzani, 1994, Journal of biological regulators and homeostatic agents.

V3 net charge: additional tool in HIV-1 tropism prediction.

O. Turriziani, G. Antonelli, M. Re, 2014, AIDS research and human retroviruses.

Human immunodeficiency virus (HIV) DNA load and level of immunosuppression in treatment-naive HIV-1-infected patients.

C. Scagnolari, G. Antonelli, M. Capobianchi, 2003, The Journal of infectious diseases.

Adherence to SARS-CoV-2 Vaccination Recommendations among Patients with Substance Use Disorders: A Cross-Sectional Study in Rome, Italy

G. Antonelli, A. Badiani, V. Cammalleri, 2023, Vaccines.

Molecular study of the presence and transcriptional activity of HPV in semen

A. Pierangeli, G. Antonelli, E. N. Cavallari, 2023, Journal of endocrinological investigation.